FDA溶出度方法库(AI中文)2730条
药品名称
剂型
USP溶出方法
转速（转/min）
溶出介质
容积
荐采样时间
更新时间
Posaconazole
Tablet (Delayed Release)
II (Paddle)
75
酸级：0.01 N HCl：缓冲液级：50 mM磷酸盐缓冲液，pH 6.8，含0.37％的聚山梨酯80（至酸级120分钟后，添加250 mL的0.2M磷酸盐缓冲液，1.46％聚山梨酯80）
酸阶段：120；缓冲阶段：10、15、20、30和45
Posaconazole
Oral Suspension
II (Paddle)
25
0.3% SLS
900
10, 20, 30 and 45
12/03/2007
Ponatinib HCl
Tablet
I (Basket)
50
pH 2.1, KCl/HCl buffer (degassed)
900
10, 15, 20, 30, 45 and 60
09/03/2015
Pomalidomide
Capsule
II (Paddle)
50
0.1 N HCl
900
10, 15, 20, 30 and 45
05/28/2015
Pitavastatin Calcium
Tablet
I (Basket)
35
0.05 M Phosphate Buffer, pH 6.8
900
5, 10, 15, 20, 30 and 45
12/23/2010
Piroxicam
Capsule
Refer to USP
10/04/2012
Pirfenidone
Tablet
Refer to FDA's Dissolution Guidance, 2018
07/02/2020
Pirfenidone
Capsule
Refer to FDA's Dissolution Guidance, 2018
07/02/2020
Pioglitazone HCl
Tablet
II (Paddle)
75
HCl-0.3 M KCl Buffer, pH 2.0
900
5, 10, 15 and 30
02/13/2004
Pindolol
Tablet
Refer to FDA's Dissolution Guidance, 2018
07/02/2020
Pimozide
Tablet
Refer to USP
02/19/2008
Pimavanserin Tartrate
Tablet
Refer to FDA's Dissolution Guidance, 2018
07/02/2020
Pilocarpine HCl
Tablet
Refer to FDA's Dissolution Guidance, 2018
07/02/2020
Phytonadione
Tablet
Develop a dissolution method
03/25/2010
Phenytoin Sodium
Capsule
Refer to USP
06/18/2007
Phenytoin
Suspension
Refer to USP
06/18/2007
Phenytoin
Tablet (Chewable)
Refer to USP
01/14/2008
Phentermine HCl/Topiramate
Capsule (Extended Release)
I (Basket)
100
Water (deionized and degassed)
750
Phentermine: 10, 15, 20, 30 and 45; Topiramate: 0.5, 1, 2, 3, 4, 6 and 8 hours
06/06/2013
Phentermine HCl
Capsule
Refer to FDA's Dissolution Guidance, 2018
07/02/2020
Phentermine HCl
Tablet (Orally Disintegrating)
II (Paddle)
50
Water
5, 10, 15, 20 and 30
07/31/2013